1.
Parimi S, Tsang E, Alexander A, McKenzie M, Bachand F, Sunderland K, Chi KN, Aparicio M, Worsley D, Tyldesley S. A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion. CUAJ [Internet]. 2017 Oct. 12 [cited 2021 Dec. 5];11(10):350-5. Available from: https://cuaj.ca/index.php/journal/article/view/4415